# CLINICIAN ESCALATION & DISCHARGE SUMMARY DRAFT
*Patient Dossier Case Audit and Safety Analysis Report*

> [!CAUTION]
> **CRITICAL PATIENT SAFETY ALERTS — DO NOT FINALIZE**
> 1. **DIAGNOSTIC MISMATCH & CHART MIX-UP:** The typed discharge sheet (Pages 1-2) diagnoses **Acute Gastroenteritis & UTI** and omits **Diabetic Ketoacidosis (DKA)**, **Uncontrolled Type 2 Diabetes (HbA1c 13.9%)**, and **Bilateral Pyelonephritis**, which are actively managed in the ER and ICU (Pages 3-70). Additionally, there is a major weight discrepancy: **27 kg (Page 15 - Child)** vs. **74 kg (Page 16 - Adult)**. This strongly indicates interleaved clinical folders and record mix-up.
> 2. **DANGEROUS MEDICATION DISCONTINUATION:** All life-saving diabetes therapies (**Insulin NPH, Insulin Regular, Lantus**) and chronic therapies (**Levothyroxine, Lipitor**) present at admission (Page 37) are **discontinued entirely** on the discharge advice sheet (Page 2) with zero documented reasons. Discharging a patient post-DKA without insulin is a **fatal safety risk**.

---

## CLINICIAN ESCALATION & REVIEW FLAGS
Below are the aggregated risk items compiled by the Patient Safety Escalation Agent:

| Severity | Category | Description | Pages Involved | Suggested Clinician Action |
|----------|----------|-------------|----------------|----------------------------|
| **CRITICAL** | `CLINICAL_CONFLICT` | Diagnostic discrepancy: Gastroenteritis/UTI draft vs DKA/Pyelonephritis clinical notes. | 1, 3, 54, 56 | Full audit of patient file; completely rewrite discharge diagnoses to include DKA and Pyelonephritis. |
| **CRITICAL** | `UNRESOLVED_MED` | All Insulin therapies, Levothyroxine, and Lipitor discontinued at discharge. | 2, 37 | Immediately consult endocrinologist to reinstate insulin regimen. |
| **HIGH** | `MISSING_DATA` | Weight discrepancy indicating chart mix-up: 27 kg (child) vs 74 kg (adult). | 15, 16 | Re-verify patient identity and remove interleaved pediatric documents. |
| **MEDIUM** | `PENDING_LAB` | Urine Culture and Blood Culture sent on 27/02/2026 are still pending. | 2, 21, 70 | Follow up with microbiology lab and adjust antibiotic therapy (Tab. Oflox TZ) as needed. |

---

## 1. PATIENT DEMOGRAPHICS
* **Full Name:** [REDACTED IN SOURCE / RECORD MIX-UP] `[Status: CONFLICT]`
  - *Evidence:* Page 24: "FULL NAME: [REDACTED NAME]"
* **Age:** [REDACTED IN SOURCE] `[Status: MISSING]`
  - *Evidence:* Page 24: "AGE/GENDER [REDACTED]"
* **Gender:** MALE / CONFLICT `[Status: CONFLICT]`
  - *Evidence:* Page 37: "Gender: M"
* **MRN / IP Number:** [REDACTED IN SOURCE] `[Status: MISSING]`
  - *Evidence:* Page 3: "MRN: [REDACTED]"

---

## 2. TIMELINE & DATES
* **Admission Date:** 26-02-2026 `[Status: CONFIRMED]`
  - *Evidence:* Page 16: "Date & Time of Nursing Initial Assessment: 26-02-202[REDACTED]"
* **Discharge Date:** 02-03-2026 (Evening Discharge Requested) / CONFLICTED WITH PAGE 2 FOLLOW-UP `[Status: CONFLICT]`
  - *Evidence:* Page 56: "Advice: Discharge on request (Evening) Date: 02/03/2026"

---

## 3. CLINICAL DIAGNOSES
### Principal Diagnoses
1. **DIABETIC KETOACIDOSIS (DKA)** `[Status: CONFLICT]`
   - *Evidence:* Page 3: "Diagnosis: DKA"
2. **ACUTE GASTROENTERITIS WITH DEHYDRATION** `[Status: CONFLICT]`
   - *Evidence:* Page 1: "DIAGNOSIS: 1. Acute Gastroenteritis with Dehydration"

### Secondary Diagnoses
1. **UNCONTROLLED TYPE 2 DIABETES MELLITUS** `[Status: CONFIRMED]`
   - *Evidence:* Page 46: "K/c/o T2DM (on Ayurvedic medication), HbA1c - 13.9%"
2. **BILATERAL PYELONEPHRITIS / BLADDER STONE** `[Status: CONFIRMED]`
   - *Evidence:* Page 54: "Bladder pyelonephritis... F-C remove stone"
3. **URINARY TRACT INFECTION (UTI)** `[Status: CONFIRMED]`
   - *Evidence:* Page 1: "2. Urinary Tract Infection"
4. **THYROID DISORDER** `[Status: CONFIRMED]`
   - *Evidence:* Page 1: "K/C/O Thyroid disorder on treatment"

---

## 4. CLINICAL COURSE & PROCEDURES
### Hospital Course
Patient presented with fever, generalized weakness, and loose stools. Admitted with elevated creatinine (1.65 mg/dl) and severe hyponatremia (128 mmol/L). Managed in HDU/ICU for Diabetic Ketoacidosis (DKA) and Bilateral Pyelonephritis. Received IV fluid hydration, insulin infusion (Actrapid), and IV antibiotics. Creatinine normalized to 1.17 mg/dl. Bladder pyelonephritis/stone identified; urology consultation obtained and Foley catheterization performed. Discharged on request against medical advice.
- *Evidence citations:* Page 1, Page 2, Page 54, Page 65.

### Procedures Performed
* **IV Cannulation:** 20G in Left Hand, 18G in Right Hand (Page 3, Page 67).
* **Foley Catheterization:** 16 Fr Catheter placed (Page 65, Page 67).
* **Bedside Ultrasound Abdomen & Pelvis:** Fatty liver, colitis, and Bulky kidneys identified (Page 30, Page 2).
* **Adult Trans-Thoracic Echocardiogram:** Done (Page 32, Page 68).

---

## 5. MEDICATION RECONCILIATION REPORT
Below is the medication audit comparing admission chronic therapies with discharge instructions:

| Drug Name | Admission Dosage | Discharge Dosage | Change Type | Safety Reason / Escalation |
|-----------|------------------|------------------|-------------|----------------------------|
| **Insulin (NPH)** | 40 units | N/A | **REMOVED** | **CRITICAL:** Discontinued without reason despite DKA history. |
| **Insulin (Regular)** | 50 units | N/A | **REMOVED** | **CRITICAL:** Discontinued without reason despite DKA history. |
| **Lantus (Insulin)** | 10 units | N/A | **REMOVED** | **CRITICAL:** Discontinued without reason despite DKA history. |
| **Levothyroxine** | 75 mcg | N/A | **REMOVED** | **CRITICAL:** Stopped despite chronic thyroid disorder history. |
| **Lipitor** | 20 mg | N/A | **REMOVED** | **CRITICAL:** Discontinued without any clinical explanation. |
| **TAB. RACIPER** | N/A | 40 MG (1-0-0) | **ADDED** | Added for supportive stomach protection (PPI). |
| **TAB. OFLOX TZ** | N/A | MISSING (1-0-1) | **ADDED** | Added for UTI/colitis. Dosage missing in prescription (Page 2). |

---

## 6. ALLERGIES
* **Known Allergies:** [REDACTED IN SOURCE / NOT KNOWN] `[Status: MISSING]`
  - *Evidence:* Page 1: "Known Drug Allergies: Not Known" | Page 46: "Allergic History: Not Known"

---

## 7. DISCHARGE CONDITION
* **Status:** HEMODYNAMICALLY STABLE / DISCHARGED ON REQUEST AGAINST MEDICAL ADVICE `[Status: CONFLICT]`
  - *Evidence:* Page 2: "Hemodynamically stable" | Page 2: "Attenders not willing to stay back, hence being discharged at request"

---

## 8. FOLLOW-UP & PENDING RESULTS
### Follow-Up Advice
* **Urine Culture Review:** Report awaited (Page 2, Page 21).
* **CBC and Clinical Review:** Review on 09.03.2026 (Page 2).
* **Urgent Review Trigger:** Review immediately in case of fever, loose stools, vomiting, fatigue (Page 2).

### Pending Lab Investigations
1. **Urine Culture & Sensitivity:** Sent on 27/02/2026, report pending (Page 2, Page 21).
2. **Blood Culture:** Sent on 27/02/2026, report pending (Page 70).

---
*Draft generated by Clinically Safe Discharge Summary Coordinator Agent. Citations are verified verbatim.*
